China to India: Vati Import Trade Route
India has recorded 9 verified shipments of Vati imported from China, representing a combined trade value of $1.3K USD. This corridor is served by 5 active China exporters, with an average shipment value of $139 USD. The leading China supplier is SINO BIOLOGICAL INC , which accounts for 28% of total import value with 1 shipments worth $351 USD. On the buying side, KRISHGEN BIOSYSTEMS is the largest Indian importer with $351 USD in purchases. The top 3 suppliers — SINO BIOLOGICAL INC , ABBKINE SCIENTIFIC CO. LTD. , WUHAN FEIYUE BIOTECHNOLOGY CO. LTD. — together control 72% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill of entry records. Values reported in FOB USD.

Route Intelligence Overview
The China to India Vati corridor is one of India's established pharmaceutical import routes from China, with 9 shipments documented worth a combined $1.3K USD. The route is dominated by SINO BIOLOGICAL INC , which alone accounts for roughly 28% of all import value, reflecting the consolidated nature of China's vati export sector.
Across 5 active China suppliers, the average shipment value stands at $139 USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (16%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during October–December, with an average transit time of 25 days port-to-port. The route has recorded an annual growth rate of 27.8%, placing it at rank #9 among India's top vati import origins globally.
On the Indian buyer side, key Indian importers include KRISHGEN BIOSYSTEMS , AMPLICON BIOTECH , AMPLICON BIOTECH and 2 others. KRISHGEN BIOSYSTEMS is the single largest Indian importer with 1 shipments valued at $351 USD.
Route Characteristics
- Average transit25 days
- Peak seasonQ4
- Primary modeMulti-modal
- Top port of entryDELHI AIR CARGO ACC (INDEL4)
Market Position
- Global rank#9
- Annual growth+27.8%
- Demand growth+23.4%
- Regulatory ease67/100
Top 10 Vati Exporters from China to India
Showing top 10 of 5 China suppliers exporting Vati to India, ranked by total trade value (USD)
| Rank | Supplier (China Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SINO BIOLOGICAL INC Avg $351 per shipment | 1 | $351 | 28.1% |
| 2 | ABBKINE SCIENTIFIC CO. LTD. Avg $141 per shipment | 2 | $282 | 22.5% |
| 3 | WUHAN FEIYUE BIOTECHNOLOGY CO. LTD. Avg $88 per shipment | 3 | $263 | 21.0% |
| 4 | WUHAN SITAILI MEDICAL APPARATUS DEVELOPMENT CO.,LT Avg $258 per shipment | 1 | $258 | 20.6% |
| 5 | CASMA THERAPEUTICS Avg $49 per shipment | 2 | $98 | 7.8% |
This table shows the top 10 of 5 China companies exporting vati to India, ranked by total trade value. The listed exporters are: SINO BIOLOGICAL INC , ABBKINE SCIENTIFIC CO. LTD. , WUHAN FEIYUE BIOTECHNOLOGY CO. LTD., WUHAN SITAILI MEDICAL APPARATUS DEVELOPMENT CO.,LT, CASMA THERAPEUTICS . SINO BIOLOGICAL INC is the dominant supplier with 1 shipments worth $351 USD, giving it a 28% market share. The top 3 suppliers together account for 72% of the total trade value on this route.
Top 10 Indian Vati Importers from China
Showing top 10 of 5 known Indian buyers receiving Vati shipments from China, ranked by import value
On the receiving end of this trade route, the leading Indian importers of China vati include KRISHGEN BIOSYSTEMS , AMPLICON BIOTECH , AMPLICON BIOTECH, MERIL MEDICAL INNOVATIONS PRIVATE LIMITED, ARAGEN LIFE SCIENCES PRIVATE LIMITED . The largest importer is KRISHGEN BIOSYSTEMS , accounting for $351 USD across 1 shipments — representing 28% of all vati imports from China on this route.
| Rank | Indian Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | KRISHGEN BIOSYSTEMS | 1 | $351 | 28.1% |
| 2 | AMPLICON BIOTECH | 2 | $282 | 22.5% |
| 3 | AMPLICON BIOTECH | 3 | $263 | 21.0% |
| 4 | MERIL MEDICAL INNOVATIONS PRIVATE LIMITED | 1 | $258 | 20.6% |
| 5 | ARAGEN LIFE SCIENCES PRIVATE LIMITED | 2 | $98 | 7.8% |
Top 10 Vati Formulations Imported from China
Showing top 10 of 6 product formulations shipped on the China to India Vati route, ranked by trade value
India imports a wide range of vati formulations from China, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — Recombinant Protein Recombinant Human LAG3 / CD 223 / Lymphocyte activation gene 3 Protein (ECD) (FOR RESEARCH PURPOSE O — accounts for $351 USD across 1 shipments. A total of 6 product variants have been identified in the shipment records.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | Recombinant Protein Recombinant Human LAG3 / CD 223 / Lymphocyte activation gene 3 Protein (ECD) (FOR RESEARCH PURPOSE O | 1 | $351 | 28.1% |
| 2 | KTE60205 HUMAN B CELL ACTIVATION FACTOR (BAFF) ELISA KIT 96 TEST (FOR RESEARCH USE ONLY | 2 | $282 | 22.5% |
| 3 | RAWM-2721 65 MM VENT VALVE BAG OPC WITH INNOVATIVE VENT VALVE DESIGN, HIGH BARRIER FILM BAG ,HYDROCOLLOID BASEPLATE , NRAWM-2721 65 MM VENT VALVE BAG OPC WITH INNOVATIVE VENT VALV | 1 | $258 | 20.6% |
| 4 | ABQ-ES96-RANTESHU QUANTICON HUMAN RANTES (REGULATED ON ACTIVATION, NORMAL T-CELL EXP. & ELISA KIT 96T (FOR RESEARCH USEABQ-ES96-RANTESHU QUANTICON HUMAN RANTES (REGULATED ON ACTIV | 2 | $177 | 14.1% |
| 5 | ORGANIC RESEARCH SAMPLES MORPHOLINO-METHYL PIPRERIDINE DERIVATIVE 3 MG | 2 | $98 | 7.8% |
| 6 | ABQ-EC96-RACGAP1HU QUANTICON HUMAN RAC-GAP1(RAC-GTPASE ACTIVATING PROTEIN 1) ELISA KIT 96T (FOR RESEARCH USEABQ-EC96-RACGAP1HU QUANTICON HUMAN RAC-GAP1(RAC-GTPASE ACTIV | 1 | $86 | 6.8% |
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Balanced freight mix — 67% sea for bulk, 16% air for urgent orders.
Top Indian Ports of Entry
DELHI AIR CARGO ACC (INDEL4) handles the highest volume with 5 shipments. Transit time averages 25 days by sea.
Market Dynamics
India's vati imports from China are driven primarily by a handful of large-scale China manufacturers. SINO BIOLOGICAL INC with 1 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 5 active exporters signals a competitive but concentrated market — Indian buyers benefit from China supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SINO BIOLOGICAL INC , ABBKINE SCIENTIFIC CO. LTD. , WUHAN FEIYUE BIOTECHNOLOGY CO. LTD. — together account for 72% of total trade value on this route. The average shipment value of $139 USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as kte60205 human b cell activation factor (baff) elisa kit 96 test (for research use only and rawm-2721 65 mm vent valve bag opc with innovative vent valve design, high barrier film bag ,hydrocolloid baseplate , nrawm-2721 65 mm vent valve bag opc with innovative vent valv, suggesting that Indian buyers tend to consolidate orders across related product lines from the same China supplier.
On the buying side, KRISHGEN BIOSYSTEMS is the largest importer with 1 shipments worth $351 USD — representing 28% of all vati imports from China on this route.
Route Statistics
- Trade Volume
- $1.3K
- Avg. Shipment
- $139
- Suppliers
- 5
- Buyers
- 5
- Transit (Sea)
- ~25 days
- Annual Growth
- +27.8%
Unlock the Full China to India Vati Dataset
TransData Nexus provides verified shipment-level records, exporter contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 9 shipments on this route.
Frequently Asked Questions — China to India Vati Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which China companies export Vati to India?
The leading China exporters of Vati to India are SINO BIOLOGICAL INC , ABBKINE SCIENTIFIC CO. LTD. , WUHAN FEIYUE BIOTECHNOLOGY CO. LTD.. SINO BIOLOGICAL INC holds the largest market share at approximately 28% of total trade value on this route.
Q What is the total value of Vati imports from China to India?
India imports Vati from China worth approximately $1.3K USD across 9 recorded shipments. The average value per shipment is $139 USD.
Q Which Indian ports receive Vati from China?
The most active Indian port of entry is DELHI AIR CARGO ACC (INDEL4) with 5 shipments. China exporters primarily use a mix of sea and air freight for this route, with 67% of shipments going by sea and 16% by air.
Q How long does shipping take from China to India for Vati?
The average transit time for Vati shipments from China to India is approximately 25 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the China to India Vati import route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 27.8% with demand growth tracking at 23.4%. The route is ranked #9 among India's top Vati import origins globally.
Q How many China suppliers are active on this Vati import route?
There are currently 5 active China suppliers exporting Vati to India. The market is moderately concentrated with SINO BIOLOGICAL INC accounting for 28% of total shipment value.
Q Who are the main Indian importers of Vati from China?
The leading Indian importers of Vati from China include KRISHGEN BIOSYSTEMS , AMPLICON BIOTECH , AMPLICON BIOTECH, MERIL MEDICAL INNOVATIONS PRIVATE LIMITED, ARAGEN LIFE SCIENCES PRIVATE LIMITED . KRISHGEN BIOSYSTEMS is the largest buyer with 1 shipments worth $351 USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to China export trade corridor identified from Indian Customs (DGFT) records for Vati.
- 2.Supplier/Buyer Matching: 5 Indian exporters and 5 importers in China matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 9 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
9 Verified Shipments
5 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists